Close
Achema middle east
swop processing & packaging

Innovacyn introduces eye, ear formulations

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

FDA Looks to Accelerate Biosimilar Drug Development

The FDA has gone on to propose certain new...

Advanced Sterile Manufacturing: Innovations Driving Aseptic Precision

Sterile pharmaceutical manufacturing represents one of the most technically...

J&J Buys Halda for $3bn to Own the Cell Death Platform

Johnson & Johnson will be paying $3.05 billion so...
- Advertisement -

Innovacyn, a provider of human and animal healthcare products, has added Vetericyn VF Ophthalmic Wash and Vetericyn VF Otic Rinse to its professional-strength animal healthcare line.

The antimicrobial solution found in the Ophthalmic Wash and Otic Rinse inhibits antibiotic-resistant strains of bacteria (including staph and MRSA) as well as fungi, viruses and spores.

Innovacyn claims Ophthalmic Wash and Otic Rinse are steroid-free, antibiotic-free and contain no alcohol or iodine and consists of oxychlorine compounds similar to those produced by the animal’s own immune system.

The Vetericyn VF Ophthalmic Wash is a twist-top that cleans wounds, eliminates the eye infections caused by viruses or fungi, and inhibits bacteria.

It also works as a no-rinse flush to relieve irritated eyes, or debride eye abrasions and wounds in the surrounding area of the eye.

The Vetericyn VF Otic Rinse inhibits infections, cleans wounds, and speeds the healing process in the outer ear and ear canal and also eliminates skin irritation.

 

Latest stories

Related stories

FDA Looks to Accelerate Biosimilar Drug Development

The FDA has gone on to propose certain new...

Advanced Sterile Manufacturing: Innovations Driving Aseptic Precision

Sterile pharmaceutical manufacturing represents one of the most technically...

J&J Buys Halda for $3bn to Own the Cell Death Platform

Johnson & Johnson will be paying $3.05 billion so...

CRISPR and Gene Editing: Next-Gen Manufacturing Impacts

The pharmaceutical and biotechnology industries are experiencing a profound...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »